The "North America AI-assisted Medical Imaging Market 2025-2032" has been added to ResearchAndMarkets.com's offering.

The AI in medical imaging market in North America is poised for substantial growth, with projections indicating an expansion to approximately USD 13.2 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of about 30%.

The driving factors behind this impressive trajectory include increased reimbursement incentives, the purchasing power of large integrated delivery networks (IDNs), regulatory advancements, and cross-border vendor collaborations.

Key Growth Drivers

• Reimbursement Incentives: Dominance by the U.S. market is bolstered by favorable reimbursement policies, notably the Centers for Medicare & Medicaid Services' (CMS) New Technology Add-On Payment (NTAP) renewals for stroke AI. Additionally, new Current Procedural Terminology (CPT) codes facilitate the adoption of CT-FFR, echo strain, and breast-AI technologies.
• Enterprise Buying Power: U.S. IDNs are increasingly securing multi-year licenses for comprehensive AI solutions, accelerating expenditure alongside the ever-expanding volume of scans.
• Regulatory Advancements: The FDA's draft plan for predetermined change-control reduces the need for re-filing during algorithm updates, thus streamlining refresh cycles and enhancing annual recurring revenue (ARR).
• Canadian Market Dynamics: Despite a cautious approach due to single-payer healthcare structures, national screening initiatives and positive health technology assessments (HTAs) are driving AI adoption. Canada's market is experiencing a lower CAGR of 29%, with a potential doubling of market size every three years.
• Cross-Border Vendor Success: U.S.-based cloud-AI providers are increasingly capturing Canadian contracts by demonstrating compliance with privacy regulations such as PIPEDA and HIPAA.

Strategic Insights and Opportunities

• Market Strategy: The North American go-to-market (GTM) growth matrix and maturity matrix provide strategic insights, supported by comprehensive datasets and regulatory intelligence along with an M&A watchlist for staying ahead in the market.
• Regional Playbooks: Detailed GTM radars, channel and pricing strategies, customer segmentation, and actionable timelines for both the U.S. and Canadian markets offer critical guidance for stakeholders.
• In-depth Forecasting: The report offers detailed analyses across various parameters, including country, modality, clinical application, and revenue streams with projections extending through 2032.

Key Topics Covered:

SECTION 1 - EXECUTIVE SUMMARY

• Size & Trajectory
• Modality & Attach rate Dynamics
• Buyer & Route to Market
• Competitive Temperature
• What to do in the Next 12 Months

SECTION 2 - RESEARCH METHODOLOGY

• Objective & Scope
• Dual lens Architecture
• North America-specific Evidence Stack & Weights
• Calibration Choices (NA)

SECTION 3 - NORTH AMERICAN MARKET

• Market Summary
• Market Size & Drivers
• Latest Trends
• Strategic Outlook
• Competitive Environment
• New Focus Areas
• North American Market Estimates & Forecasts (2023-2032)
• AI Imaging Market by Country - North America

SECTION 4 - UNITED STATES MARKET

• Market Summary - United States
• Key Market Dynamics
• Strategic Takeaways
• Top 3 Recommendations
• Market Overview - United States

SECTION 5 - CANADIAN MARKET

• Market Summary: Canada
• Key Market Dynamics
• Strategic Takeaways
• Top 3 Recommendations
• Market Overview - Canada

For more information about this report visit https://www.researchandmarkets.com/r/8b62df

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251028437714/en/